Prediction models for the risk of new-onset hypertension in ethnic Chinese in Taiwan
暂无分享,去创建一个
K. Chien | F. Sung | T. Su | H. Hsu | W. Chang | M‐F Chen | Y.t. Lee | K-L Chien | H-C Hsu | T-C Su | W-T Chang | F-C Sung | M-F Chen | Y-T Lee | M.‐F. Chen
[1] M. Pencina,et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.
[2] Robert Tibshirani,et al. An Introduction to the Bootstrap , 1994 .
[3] W. Elliott. Hyperuricemia and Incidence of Hypertension Among Men Without Metabolic Syndrome , 2008 .
[4] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[5] D. Levy,et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. , 1997, Circulation.
[6] K. Chien,et al. Two-year change in body mass index and subsequent risk of hypertension among men and women in a Taiwan community , 2009, Journal of hypertension.
[7] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[8] J. Hanley,et al. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.
[9] N. Cook. Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.
[10] P. Ridker,et al. A prospective study of plasma lipid levels and hypertension in women. , 2005, Archives of internal medicine.
[11] Piotr Ponikowski,et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.
[12] Nader Rifai,et al. Multiple Biomarkers and the Risk of Incident Hypertension , 2007, Hypertension.
[13] S. Pocock,et al. Incidence , , 2018 .
[14] Nancy R Cook,et al. Prediction of incident hypertension risk in women with currently normal blood pressure. , 2009, The American journal of medicine.
[15] J. Oppert,et al. Relationships between changes in weight and changes in cardiovascular risk factors in middle-aged French subjects: effect of dieting , 2002, International Journal of Obesity.
[16] K. Chien,et al. Urinary sodium and potassium excretion and risk of hypertension in Chinese: report from a community-based cohort study in Taiwan , 2008, Journal of hypertension.
[17] F. Hu,et al. A prediction model for type 2 diabetes risk among Chinese people , 2009, Diabetologia.
[18] M. Jokela,et al. Validating the Framingham Hypertension Risk Score: Results From the Whitehall II Study , 2009, Hypertension.
[19] A. LaCroix,et al. The prediction of midlife coronary heart disease and hypertension in young adults: the Johns Hopkins multiple risk equations. , 1990, American journal of preventive medicine.
[20] K. Chien,et al. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. , 2005, Atherosclerosis.
[21] L. Irwig,et al. Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide. , 2008, Archives of internal medicine.
[22] K. Chien,et al. Incidence of hypertension and risk of cardiovascular events among ethnic Chinese: report from a community-based cohort study in Taiwan , 2007, Journal of hypertension.
[23] P. Vokonas,et al. Uric Acid and the Development of Hypertension: The Normative Aging Study , 2006, Hypertension.
[24] A. Dominiczak,et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.
[25] F. Hu,et al. patient-oriented and epidemiological research Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese , 2007 .
[26] Stanley Lemeshow,et al. The Multiple Logistic Regression Model , 2013 .
[27] P. Ridker,et al. C-reactive protein and the risk of developing hypertension. , 2003, JAMA.
[28] T. Erlinger,et al. Blood pressure change and risk of hypertension associated with parental hypertension: the Johns Hopkins Precursors Study. , 2008, Archives of internal medicine.
[29] D. Levy,et al. A Risk Score for Predicting Near-Term Incidence of Hypertension: The Framingham Heart Study , 2008, Annals of Internal Medicine.
[30] Michael Böhm,et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.
[31] M. Janghorbani,et al. Hypertension in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors. , 2005, Diabetes research and clinical practice.
[32] F. Hu,et al. Plasma uric acid and the risk of type 2 diabetes in a Chinese community. , 2008, Clinical chemistry.
[33] Renata Cifkova,et al. Erratum: Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology (Journal of Hypertension (2007) 25, (1105-1187)) , 2007 .
[34] C-reactive protein and the risk of developing hypertension. , 2003 .
[35] Y. T. Lee,et al. Lipoprotein (a) level in the population in Taiwan: relationship to sociodemographic and atherosclerotic risk factors. , 1999, Atherosclerosis.
[36] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[37] G. Berti,et al. Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. , 1980, Clinical chemistry.
[38] G. Cutter,et al. Three-year incidence of hypertension in thirteen U.S. communities. On behalf of the Hypertension Detection and Follow-up Program cooperative group. , 1982, Preventive medicine.
[39] A. Dominiczak,et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.
[40] S. T. Buckland,et al. An Introduction to the Bootstrap. , 1994 .
[41] Albert Damon,et al. The Normative Aging Study: An Interdisciplinary and Longitudinal Study of Health and Aging , 1972 .
[42] D. Levy,et al. Relations of Serum Uric Acid to Longitudinal Blood Pressure Tracking and Hypertension Incidence , 2005, Hypertension.
[43] J. Manson,et al. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes , 2004, Diabetologia.
[44] R. D'Agostino,et al. Presentation of multivariate data for clinical use: The Framingham Study risk score functions , 2004, Statistics in medicine.
[45] F. Sung,et al. Chin-Shan Community Cardiovascular Cohort in Taiwan-baseline data and five-year follow-up morbidity and mortality. , 2000, Journal of clinical epidemiology.
[46] D. Altman,et al. Comparing methods of measurement: why plotting difference against standard method is misleading , 1995, The Lancet.
[47] M. Stampfer,et al. Diet and lifestyle risk factors associated with incident hypertension in women. , 2009, JAMA.
[48] K. Chien. An Accurate Risk Score Based on Anthropometric, Dietary, and Lifestyle Factors to Predict the Development of Type 2 Diabetes , 2007, Diabetes Care.
[49] T. Erlinger,et al. Serum Uric Acid Predicts Incident Hypertension in a Biethnic Cohort: The Atherosclerosis Risk in Communities Study , 2006, Hypertension.
[50] Sudha Seshadri,et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.
[51] Kuan-Hung Lin,et al. Uric acid and the development of hypertension. , 2010, Medical science monitor : international medical journal of experimental and clinical research.